Matrix Laboratories
Last board
1 office holder, 1 auditor, last change in July 2026Deed of 02-07-2026 resigns as statutory auditor reappointed as statutory auditor · General meeting of 18-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 06-02-2024
Mandates through the years
1 name, the dashed line is todayStatutory auditor
Rest of the term
Mandates as a list
-
- Statutory auditor, appointed by deed of 25-09-2009, still in office
With Starter you also see 8 former office holders in the mandate history.
See the plans →
Control
Consolidating parent
US
consolidates
This company
Matrix Laboratories
Equity -€16.2m
Loss €27,627 in 2025
Capital
- Contribution
- €141,033,023.74
- Shares
- 264,500
- Contribution per share
- €533
- Equity per share
- -€61.24 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themSource: shareholder structure in its own accounts, parent in its own accounts
Articles of association
deed of 06-02-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June at 18:00
Shareholders
3 ownersOwners 3
- LUparentSourceown accounts 202560%
- USconsolidating parentconsolidates
- LUSourceown accounts 202540%
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 22-02-2010 ↗
- 1 share
- 158,700,000 shares
Capital over time
- 06-02-2024 Converted to available equity
- 14-12-2010 Capital reduction of €700,000 · to €141,033,023.74 · repaid to the shareholders
- 22-02-2010 Capital stated in the deed · €141,733,023.74 · 264,500,000 shares
- 18-01-2010 Capital reduction of €47,610,277 · to €58,189,723
- 18-01-2010 Capital increase of €87,285,000 · to €145,474,723 · 158,700,000 new shares · in kind
- 18-01-2010 Capital increase of €35,029,000 · to €180,503,723 · no new shares · “omzetting in kapitaal van bedrag afgenomen van rekening Uitgiftepremies”
- 18-01-2010 Capital reduction of €38,770,699.26 · to €141,733,023.74 · to absorb losses